Pay in installments of $7.04 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
ERYFOTONA AK-NMSC SPF 100+ FLUIDDESCRIPTION Prevents and repairs actinic damage. Gives your skin a new chance. Prevention and protective adjuvant treatment for actinic keratosis (AK) and other forms of non melanoma skin cancer (NMSC). Reduces and improves the subclinical cutaneous cancerisation field associated with actinic keratosis and non melanoma skin cancer. Prevents actinic damage caused by the sun and encourages its repair. Creates a protective film of ADN Repairsomes on the
DESCRIPTION
Prevents and repairs actinic damage. Gives your skin a new chance. Prevention and protective adjuvant treatment for actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC). Reduces and improves the subclinical cutaneous cancerisation field associated with actinic keratosis and non-melanoma skin cancer.Prevents actinic damage caused by the sun and encourages its repair. Creates a protective film of ADN Repairsomes on the skin that helps to protect against new lesions. Furthermore, continued use helps DNA's natural repair mechanism.
HOW TO USE
Apply liberally to the affected area twice a day, in the morning and at midday. Photolyase is activated by visible light.INGREDIENTS
Repairsomes® (UVB-UVA Filter complex+ plankton extract), Bisabolol, Tocopheryl acetate, Panthenol, ExcipientsShipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.7 ★★★★★
Based on 21 reviews
Sort
Product Reviews
★★★★★ 5
Unexpectedly awesome
Format: Paperback
After reading the first chapter, I was expecting a Demon Slayer clone. I should have known better, given the author! The story took a twist and I am all in. Great action and humor so far. Can't wait for the next one!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 17, 2024
★★★★★ 4
AN Interesting Genre Blend
Format: Paperback
Well, this is a weird one (in a good way...I think).
47 heroes are selected, one for each of the demon kings. The heroes are sent out to destroy the demon kings and regain the world back for humanity. It's a bit bleak though...The 11th hero is in a rut, but a strange group with specialized weapons (firearms as opposed to swords) comes and obliterates a group of demons. Has the call been answered? While they may think that, the group has actually sought them for aid to fight against these AI robots that have taken over humanity. Can the two groups help each others worlds across dimensions?
This manga offers an interesting genre blend of fantasy and futuristic technology. The art is great, as expected of the mangaka of One Punch Man, and some of the characters are certainly more intriguing than others. This is definitely a fun action-packed manga that fits the shounen genre.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 19, 2024
★★★★★ 5
Love this!
Format: Kindle
The twist is what hooked me! Can't wait for vol 2!
Love the story so far in the book and the art great!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 12, 2025
★★★★★ 5
Beautiful start
Format: Paperback
This series had definitely got me wanting more, I love it and will be waiting for more!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 15, 2025
★★★★★ 5
Very good
Format: Paperback
Manga received with no damage. Satisfied customer
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 25, 2025